Dasatinib and Quercetin to Treat Fibrotic Non-alcoholic Fatty Liver Disease

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
To examine the effect of dasatinib plus quercetin on liver fibrosis in individuals with biopsy proven NAFLD with fibrosis by performing a double-blind randomized controlled proof-of-principle study
Epistemonikos ID: b0940e12b0de5b5a1ebd05ed8a0813c80cf655b0
First added on: May 13, 2024